Systematic studies of a possible human neuropathogenicity of the Erve
virus have not yet been carried out. In a randomized, blind study 166
patients with viral encephalitis, 46 patients with cerebral hemorrhage
, 72 patients with ''thunderclap'' headache, and 205 healthy blood don
ors were examined by indirect immunofluorescence for Erve virus antibo
dies. None of the patients with encephalitis, two patients with cerebr
al hemorrhage (4.3%), 10 patients with thunderclap headache (13.9%; p
< 0.0001), and two blood donors (1.0%) exhibited antibodies against th
e Erve virus. These results suggest a human pathogenicity of the Erve
virus for the first time.